David L. Lewis

10.4k total citations · 1 hit paper
176 papers, 6.9k citations indexed

About

David L. Lewis is a scholar working on Molecular Biology, Sociology and Political Science and Health, Toxicology and Mutagenesis. According to data from OpenAlex, David L. Lewis has authored 176 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 29 papers in Sociology and Political Science and 19 papers in Health, Toxicology and Mutagenesis. Recurrent topics in David L. Lewis's work include Race, History, and American Society (26 papers), RNA Interference and Gene Delivery (19 papers) and Magnetism in coordination complexes (11 papers). David L. Lewis is often cited by papers focused on Race, History, and American Society (26 papers), RNA Interference and Gene Delivery (19 papers) and Magnetism in coordination complexes (11 papers). David L. Lewis collaborates with scholars based in United States, Canada and Australia. David L. Lewis's co-authors include Jon A. Wolff, James E. Hagstrom, Hans Herweijer, Derek J. Hodgson, A. G. Loomis, David B. Rozema, William E. Hatfield, So C. Wong, David K. Gattie and Darren H. Wakefield and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

David L. Lewis

165 papers receiving 6.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes

2007 523 citations David B. Rozema, David L. Lewis et al. Proceedings of the National Academy of Sciences profile →

Peers

Countries citing papers authored by David L. Lewis

Since Specialization

Citations

This map shows the geographic impact of David L. Lewis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David L. Lewis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David L. Lewis more than expected).

Fields of papers citing papers by David L. Lewis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David L. Lewis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David L. Lewis. The network helps show where David L. Lewis may publish in the future.

Co-authorship network of co-authors of David L. Lewis

This figure shows the co-authorship network connecting the top 25 collaborators of David L. Lewis. A scholar is included among the top collaborators of David L. Lewis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David L. Lewis. David L. Lewis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development of an RNAi therapeutic for alpha-1-antitrypsin liver disease 2020 ·JCI Insight ·Christine I. Wooddell, Keith Blomenkamp, Ryan M. Peterson, Владимир Субботин, Christian Schwabe, James Hamilton, Qili Chu, Dawn R. Christianson, Julia Hegge, John Kolbe, Holly Hamilton, (unknown), Bruce D. Given, David L. Lewis, Edward Gane, Steven B. Kanner, Jeffrey Teckman	40
2	HIF2α-Targeted RNAi Therapeutic Inhibits Clear Cell Renal Cell Carcinoma 2017 ·Molecular Cancer Therapeutics ·So C. Wong, Weijun Cheng, Holly Hamilton, (unknown), Darren H. Wakefield, (unknown), Andrei V. Blokhin, Jeffrey Carlson, Zane C. Neal, Владимир Субботин, Guofeng Zhang, Julia Hegge, Stephanie Bertin, Vladimir S. Trubetskoy, David B. Rozema, David L. Lewis, Steven B. Kanner	27
3	RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg 2017 ·Science Translational Medicine ·Christine I. Wooddell, Man‐Fung Yuen, Henry Lik‐Yuen Chan, Robert G. Gish, Stephen Locarnini, Deborah Chavez, Carlo Ferrari, Bruce D. Given, James Hamilton, Steven B. Kanner, Ching‐Lung Lai, Johnson Y.N. Lau, Thomas Schluep, (unknown), Robert E. Lanford, David L. Lewis	342
4	Protease-triggered siRNA delivery vehicles 2015 ·Journal of Controlled Release ·David B. Rozema, Andrei V. Blokhin, Darren H. Wakefield, (unknown), Jeffrey Carlson, Jason J. Klein, (unknown), (unknown), Holly Hamilton, Qili Chu, Julia Hegge, So C. Wong, Vladimir S. Trubetskoy, (unknown), Eric Kitas, Jon A. Wolff, David L. Lewis	31
5	Hepatocyte-targeted RNAi Therapeutics for the Treatment of Chronic Hepatitis B Virus Infection 2013 ·Molecular Therapy ·Christine I. Wooddell, David B. Rozema, Markus Hoßbach, Matthias John, Holly Hamilton, Qili Chu, Julia Hegge, Jason J. Klein, Darren H. Wakefield, Claudia E. Oropeza, Jochen Deckert, Ingo Roehl, Kerstin Jahn‐Hofmann, Philipp Hadwiger, (unknown), A. McLachlan, David L. Lewis	241
6	Co-Injection of a Targeted, Reversibly Masked Endosomolytic Polymer Dramatically Improves the Efficacy of Cholesterol-Conjugated Small Interfering RNAs In Vivo 2012 ·Nucleic Acid Therapeutics ·So C. Wong, Jason J. Klein, Holly Hamilton, Qili Chu, (unknown), Vladimir S. Trubetskoy, Julia Hegge, Darren H. Wakefield, David B. Rozema, David L. Lewis	86
7	Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes breakdown → 2007 ·Proceedings of the National Academy of Sciences ·David B. Rozema, David L. Lewis, Darren H. Wakefield, So C. Wong, Jason J. Klein, P. Roesch, Stephanie Bertin, (unknown), Qili Chu, Andrei V. Blokhin, James E. Hagstrom, Jon A. Wolff	523
8	Prospective study of cross-infection from upper-GI endoscopy in a hepatitis C–prevalent population 2007 ·Gastrointestinal Endoscopy ·Nabiel Mikhail, David L. Lewis, (unknown), (unknown), (unknown), (unknown), Mohamed Abdel‐Hamid, G. Thomas Strickland	21
9	My Forty Years with Ford 2006 ·Project Muse (Johns Hopkins University) ·(unknown), David L. Lewis	19
10	A High-Level Disinfection Standard for Land-Applied Sewage Sludges (Biosolids) 2003 ·Environmental Health Perspectives ·David K. Gattie, David L. Lewis	13
11	Whistleblowing procedures at work: what are the implications for human resource practitioners? 2002 ·Business Ethics A European Review ·David L. Lewis	2
12	Interactions of pathogens and irritant chemicals in land-applied sewage sludges (biosolids) 2002 ·BMC Public Health ·David L. Lewis, David K. Gattie, (unknown), Susan Sánchez, (unknown)	33
13	ROAD USER AND MITIGATION COSTS IN HIGHWAY PAVEMENT PROJECTS 1999 ·David L. Lewis	11
14	Expression pattern of a butterfly achaete-scute homolog reveals the homology of butterfly wing scales and insect sensory bristles 1998 ·Current Biology ·(unknown), James B. Skeath, Steve Paddock, David L. Lewis, Sean B. Carroll	104
15	Resistance of microorganisms to disinfection in dental and medical devices 1995 ·Nature Medicine ·David L. Lewis, Max Q. Arens	46
16	Risks of infection with blood- and saliva-borne pathogens from internally contaminated impressions and models. 1995 ·PubMed ·David L. Lewis, Max Q. Arens, (unknown), (unknown)	6
17	Sequence, organization, and evolution of the A+T region of Drosophila melanogaster mitochondrial DNA. 1994 ·Molecular Biology and Evolution ·David L. Lewis, Carol L. Farr, (unknown), Laurie S. Kaguni	91
18	Cross-contamination potential with dental equipment 1992 ·The Lancet ·David L. Lewis, Max Q. Arens, M. Suzuki, (unknown), Keigo Nakashima, (unknown), (unknown), (unknown), (unknown)	82
19	Improving the air traffic control system : an assessment of the National Airspace System Plan, August 1983 1991 ·David L. Lewis	1
20	Vagotomy and Pyloroplasty for Gastric Ulcer 1972 ·BMJ ·Robert Clarke, David L. Lewis, J.A. Williams	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact